Cargando…

T cell immunoglobulin and mucin domain-containing protein 3 is highly expressed in patients with acute decompensated heart failure and predicts mid-term prognosis

BACKGROUND AND AIMS: T cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) is mainly expressed by immune cells and plays an immunomodulatory role in cardiovascular disease. However, the prognostic value of Tim-3 in acute decompensated heart failure (ADHF) is unclear. This study aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Xin, Xia, Guofang, Zhang, Lili, Xu, Congfeng, Chen, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520239/ https://www.ncbi.nlm.nih.gov/pubmed/36186992 http://dx.doi.org/10.3389/fcvm.2022.933532

Ejemplares similares

Implementation of a heart failure educational intervention for patients with recent admissions for acute decompensated heart failure
por: Stahlman, Sarah, et al.
Publicado: (2023)

Early administration of ivabradine in patients admitted for acute decompensated heart failure
por: Yang, Teng-Yao, et al.
Publicado: (2022)

Identification of decompensation episodes in chronic heart failure patients based solely on heart sounds
por: Susič, David, et al.
Publicado: (2022)

Vitamin D Binding Protein and Renal Injury in Acute Decompensated Heart Failure
por: Diaz-Riera, Elisa, et al.
Publicado: (2022)

Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF)
por: Ezekowitz, Justin A, et al.
Publicado: (2016)

Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials
por: Gong, Bojun, et al.
Publicado: (2016)

Case Report: Ambient Sensor Signals as Digital Biomarkers for Early Signs of Heart Failure Decompensation
por: Saner, Hugo, et al.
Publicado: (2021)

Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure: a meta-analysis
por: Chen, Shuai, et al.
Publicado: (2023)

Pulmonary Hypertension in Patients With Heart Failure With Mid-Range Ejection Fraction
por: Maeder, Micha T., et al.
Publicado: (2021)

Efficacy of tolvaptan on the short and mid-term prognosis in elderly patients with acute heart failure coexisting with oliguria: A retrospective cohort study
por: Liu, Yang, et al.
Publicado: (2023)

Development and Validation of a Prediction Model for Acute Kidney Injury Among Patients With Acute Decompensated Heart Failure
por: Wang, Lei, et al.
Publicado: (2021)

Development and Validation of a Prediction Model for Irreversible Worsened Cardiac Function in Patients With Acute Decompensated Heart Failure
por: Wang, Lei, et al.
Publicado: (2021)

Feasibility and safety of 1-min sit-to-stand test in acute decompensated heart failure confirmed by lung ultrasound
por: Zhang, Xiu, et al.
Publicado: (2023)

Sex Influence on Heart Failure Prognosis
por: Postigo, Andrea, et al.
Publicado: (2020)

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
por: Ibrahim, Ayman, et al.
Publicado: (2020)

C-reactive protein at discharge and 1-year mortality in hospitalised patients with acute decompensated heart failure: an observational study
por: Nishimoto, Yuji, et al.
Publicado: (2020)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
por: Borrelli, Chiara, et al.
Publicado: (2019)

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
por: Zhu, Kaiyuan, et al.
Publicado: (2021)

Treatment of Heart Failure With Mid-Range Ejection Fraction: A Summary of Current Evidence
por: Ma, Teng, et al.
Publicado: (2021)

Elevated Plasma Big Endothelin-1 at Admission Is Associated With Poor Short-Term Outcomes in Patients With Acute Decompensated Heart Failure
por: Mo, Ran, et al.
Publicado: (2021)

Prognostic Value of β1 Adrenergic Receptor Autoantibody and Soluble Suppression of Tumorigenicity-2 in Patients With Acutely Decompensated Heart Failure
por: Sun, Yanxiang, et al.
Publicado: (2022)

Device-based therapy for decompensated heart failure: An updated review of devices in development based on the DRI(2)P(2)S classification
por: de Oliveira Cardoso, Cristiano, et al.
Publicado: (2022)

Non-withdrawal of beta blockers in acute decompensated chronic and de novo heart failure with reduced ejection fraction in a prospective multicentre study of patients with acute heart failure in the Middle East
por: Abi Khalil, Charbel, et al.
Publicado: (2017)

In-hospital Heart Rate Reduction With Beta Blockers and Ivabradine Early After Recovery in Patients With Acute Decompensated Heart Failure Reduces Short-Term Mortality and Rehospitalization
por: Faragli, Alessandro, et al.
Publicado: (2021)

Risk factors and clinical outcomes of functional decline during hospitalisation in very old patients with acute decompensated heart failure: an observational study
por: Yaku, Hidenori, et al.
Publicado: (2020)

Heart Failure With Mid-range Ejection Fraction: A Distinctive Subtype or a Transitional Stage?
por: Zhou, Qing, et al.
Publicado: (2021)

Northern Territory Heart Failure Initiative–Clinical Audit (NTHFI–CA)–a prospective database on the quality of care and outcomes for acute decompensated heart failure admission in the Northern Territory: study design and rationale
por: Iyngkaran, Pupalan, et al.
Publicado: (2014)

Myocardial Work Assessment for the Prediction of Prognosis in Advanced Heart Failure
por: Hedwig, Felix, et al.
Publicado: (2021)

The Value of IGF-1 and IGFBP-1 in Patients With Heart Failure With Reduced, Mid-range, and Preserved Ejection Fraction
por: Guo, Shaohua, et al.
Publicado: (2022)

Influence of Waist-to-Hip Ratio on the Prognosis of Heart Failure Patients With Revascularized Coronary Heart Disease
por: Zhang, Yingyue, et al.
Publicado: (2021)

Malnutrition and infection lead to poor prognosis and heavy financial burden of patients with chronic heart failure
por: Jia, Xu, et al.
Publicado: (2022)

Cardiac decompensation of patients before transcatheter aortic valve implantation—clinical presentation, responsiveness to associated medication, and prognosis
por: Fischer-Rasokat, Ulrich, et al.
Publicado: (2023)

Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs
por: Shrivastava, Apurva, et al.
Publicado: (2020)

Association between hyperlipidemia and mortality after incident acute myocardial infarction or acute decompensated heart failure: a propensity score matched cohort study and a meta-analysis
por: Yousufuddin, Mohammed, et al.
Publicado: (2019)

Gout Arthritis During Admission for Decompensated Heart Failure—A Descriptive Analysis of Risk Factors, Treatment and Prognosis
por: Ritter, Fabian, et al.
Publicado: (2022)

Knowledge domain and emerging trends in empagliflozin for heart failure: A bibliometric and visualized analysis
por: Zhang, Xuesong, et al.
Publicado: (2022)

Deep Learning Predicts Heart Failure With Preserved, Mid-Range, and Reduced Left Ventricular Ejection Fraction From Patient Clinical Profiles
por: Alkhodari, Mohanad, et al.
Publicado: (2021)

The Female Sex Confers Different Prognosis in Heart Failure: Same Mortality but More Readmissions
por: López-Vilella, Raquel, et al.
Publicado: (2021)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

A Meta-Analysis of Growth Differentiation Factor-15 and Prognosis in Chronic Heart Failure
por: Luo, Jin-Wen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cn2i1nj982j6fta6fltuos83ih